ETON PHARMACEUTICALS INC. - COMMON STOCK

Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®

03 Jan 2025 05:50:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)

20 Dec 2024 05:50:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial

17 Dec 2024 05:50:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer

03 Dec 2024 05:50:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)

25 Nov 2024 05:50:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results

12 Nov 2024 15:01:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)

07 Nov 2024 06:00:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

06 Nov 2024 15:30:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen

03 Oct 2024 05:30:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

22 Aug 2024 15:30:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results

08 Aug 2024 15:01:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

30 Jul 2024 16:30:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

15 Jul 2024 15:05:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports First Quarter 2024 Financial Results

09 May 2024 15:01:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference

01 May 2024 15:05:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

30 Apr 2024 06:00:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

29 Apr 2024 15:30:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria

22 Mar 2024 01:00:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

14 Mar 2024 15:01:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024

29 Feb 2024 15:01:00 By Nasdaq GlobeNewswire